You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Galderma Laboratories L.P. v. Lupin Inc. (D. Del. 2021)

✉ Email this page to a colleague

« Back to Dashboard

Galderma Laboratories L.P. v. Lupin Inc. (D. Del. 2021)

Docket	⤷ Sign Up	Date Filed	2021-12-03
Court	District Court, D. Delaware	Date Terminated	2024-04-01
Cause	35:271 Patent Infringement	Assigned To	Stephanos Bibas
Jury Demand	Defendant	Referred To
Patents	7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; 8,709,478; 9,061,005
Link to Docket	External link to docket

Small Molecule Drugs cited in Galderma Laboratories L.P. v. Lupin Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Biologic Drugs cited in Galderma Laboratories L.P. v. Lupin Inc.

The biologic drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Galderma Laboratories L.P. v. Lupin Inc. (D. Del. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2023-04-07	108	Opinion - Memorandum Opinion	pharmaceutically acceptable excipients. U.S. Patent No. 8,206,740 cl. 1. Sun already construed the terms…company, Sun, for infringing the same patents. Many of the patents’ terms were construed in that suit. … slowly. Galderma patented its developments. Though Galderma has several patents and dozens of claims… “It is a bedrock principle of patent law that the claims of a patent define the in- vention to which…Galderma says Lupin infringes some of its drug patents. A few years ago, Gal- derma won a lawsuit against	External link to document
2023-04-07	109	Order	ORDER Regarding Terms of US Patent Nos. 7,749,532; 8,206,740; 8,394,405; 8,394,406; 8,470,364; …2021 1 April 2024 1:21-cv-01710 835 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document
2023-05-10	116	Stipulation of Dismissal	of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478 by …2021 1 April 2024 1:21-cv-01710 835 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document
2023-05-11	118		of Claims and Defenses Relating to U.S. Patent Nos. 8,394,405, 8,394,406, 8,470,364, and 8,709,478. Ordered…2021 1 April 2024 1:21-cv-01710 835 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document
2023-06-08	121	Notice of Service	Regarding Lupin's Infringement of U.S. Patent Nos. 7,749,532 and 8,206,740 filed by Galderma Laboratories…2021 1 April 2024 1:21-cv-01710 835 Patent - Abbreviated New Drug Application(ANDA) Defendant	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.